Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $28.0000 (-1.79%) ($27.7500 - $28.6100) on Thu. Jul. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.64% (three month average) | RSI | 73 | Latest Price | $28.0000(-1.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.4% a day on average for past five trading days. | Weekly Trend | HALO advances 6.7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(50%) IWM(47%) IWC(45%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -1.32% in a week (0% probabilities). VIXM(-32%) UUP(-15%) VXX(-14%) TLT(-2%) IYT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.32% (StdDev 2.64%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
5 Day Moving Average | $28.16(-0.57%) | 10 Day Moving Average | $27.18(3.02%) | 20 Day Moving Average | $25.67(9.08%) | To recent high | -1.8% | To recent low | 57.7% | Market Cap | $3.827b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |